Binzhi Qian, Ph.D.
Affiliations: | 2009 | Yeshiva University, New York, NY, United States |
Area:
Molecular Biology, OncologyGoogle:
"Binzhi Qian"Parents
Sign in to add mentorJeffrey W. Pollard | grad student | 2009 | Yeshiva University | |
(Characterization and functional study of macrophages associated with pulmonary metastasis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Qian BZ, Ma RY. (2025) Immune Microenvironment in Breast Cancer Metastasis. Advances in Experimental Medicine and Biology. 1464: 413-432 |
Glaviano A, Lau HS, Carter LM, et al. (2025) Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition. Journal of Hematology & Oncology. 18: 6 |
Semeniuk S, Qian BZ, Cachat E. (2024) Engineering an αCD206-synNotch Receptor: Insights into the Development of Novel Synthetic Receptors. Acs Synthetic Biology. 13: 3876-3884 |
Guo J, Ma RY, Qian BZ. (2024) Macrophage heterogeneity in bone metastasis. Journal of Bone Oncology. 45: 100598 |
Rodriguez-Tirado C, Entenberg D, Li J, et al. (2022) Interleukin 4 Controls the Pro-Tumoral Role of Macrophages in Mammary Cancer Pulmonary Metastasis in Mice. Cancers. 14 |
Ma RY, Black A, Qian BZ. (2022) Macrophage diversity in cancer revisited in the era of single-cell omics. Trends in Immunology. 43: 546-563 |
Pang X, Zhang J, He X, et al. (2021) SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways. Oxidative Medicine and Cellular Longevity. 2021: 5806602 |
Zhou Y, Yang D, Yang Q, et al. (2020) Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nature Communications. 11: 6322 |
Ma RY, Zhang H, Li XF, et al. (2020) Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth. The Journal of Experimental Medicine. 217 |
Pang X, Gong K, Zhang X, et al. (2019) Osteopontin as a Multifaceted Driver of Bone Metastasis and Drug Resistance. Pharmacological Research |